Synonyms:
Status: Phase 1
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: AJ212MS2O2

Structure

InChI Key GKMLFBRLRVQVJO-ZDUSSCGKSA-N
Smile O=C(O)c1ccc(NC(=O)[C@H](CC2CCCC2)n2cnc(C(F)(F)F)c2)nc1
InChI
InChI=1S/C18H19F3N4O3/c19-18(20,21)14-9-25(10-23-14)13(7-11-3-1-2-4-11)16(26)24-15-6-5-12(8-22-15)17(27)28/h5-6,8-11,13H,1-4,7H2,(H,27,28)(H,22,24,26)/t13-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H19F3N4O3
Molecular Weight 396.37
AlogP 3.76
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 6.0
Polar Surface Area 97.11
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
ACTIVATOR Hexokinase type IV activator PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme
190-6900 - - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetes Mellitus, Type 2 2 D003924 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1215197-37-7
ChEMBL CHEMBL2165620
DrugBank DB11765
FDA SRS AJ212MS2O2
PDB 0H6
PubChem 46181428
SureChEMBL SCHEMBL1711504
ZINC ZINC000068250431